Press Releases

AIDP expands to Australia and New Zealand with KoACT, Magtein and enVantec

CITY OF INDUSTRY, Calif. (July 18, 2012) – AIDP, Inc., the distributors of Magtein™ magnesium L-threonate a new discovery in the brain health category for cognitive health, KoACT®, a patented chelated compound of calcium and hydrolyzed collagen peptides and enVantec™, a proprietary micro-encapsulation technology, has announced that it has retained Pathway International Pty Ltd., www.pathway.net.au, to represent AIDP branded products in Australia and New Zealand. Pathway International will be the exclusive agent for both territories, initially focusing on Magtein, KoACT and enVantec.

Download this press release Share